Victory Capital
VCTR
111.85
-2.00
-1.76%
Victory Capital
US · VCTR
#1788 by market cap
Listed 2018
111.85
-2.00
-1.76%
Live - 5344 symbols - heartbeat 195s ago
· 2026-10-07 19:54
After-hours
111.85
0.00%
- Market cap
- 6.88B
- P/E (TTM)i
- 20.34
- P/Bi
- 2.90
- EPSi
- 4.08
- Div yieldi
- 1.76%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on VCTR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.42, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +46.19% YoY
Margins
- Gross margin
- 54.45%
- Operating margin
- 42.49%
- Net margin
- 20.68%
Key ratios & quality
- PEG ratioi
- 3.28
- Altman Z-Scorei
- 3.42
PEG uses trailing P/E against the 3-year net income growth rate (6.21%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 413.41M | 612.37M | 775.35M | 890.27M | 854.80M | 821.03M | 893.48M | 1.31B |
| Gross profit | 172.85M | 285.94M | 402.51M | 479.05M | 455.50M | 450.44M | 529.77M | 711.15M |
| Selling & admin expenses | 30.01M | 46.57M | 51.22M | 53.72M | 52.37M | 56.29M | 56.69M | 83.32M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 119.57M | 215.50M | 334.91M | 406.49M | 359.92M | 352.51M | 442.90M | 554.98M |
| Pretax profit | 84.91M | 120.69M | 278.54M | 350.64M | 350.03M | 275.91M | 373.76M | 438.32M |
| Tax | 21.21M | 28.20M | 66.02M | 72.25M | 74.52M | 62.75M | 84.89M | 108.26M |
| Net profit | 63.70M | 92.49M | 212.52M | 278.39M | 275.51M | 213.16M | 288.86M | 330.06M |
| Basic EPS | 1 | 1 | 3 | 4 | 4 | 3 | 4 | 4 |
| Diluted EPS | 0.90 | 1.26 | 2.88 | 3.75 | 3.81 | 3.12 | 4.38 | 4.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 219.60M | 351.21M | 361.20M | 374.12M | 387.99M | 435.36M |
| Gross profit | 162.38M | 247.77M | 257.10M | 43.90M | 281.90M | 327.50M |
| Selling & admin expenses | 48.72M | 90.89M | 82.51M | -138.80M | 87.80M | 109.15M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 106.23M | 135.08M | 152.56M | 161.11M | 173.53M | 197.77M |
| Pretax profit | 80.40M | 86.99M | 129.27M | 141.66M | 147.86M | 187.25M |
| Tax | 18.43M | 28.25M | 32.73M | 28.85M | 35.72M | 47.85M |
| Net profit | 61.98M | 58.73M | 96.54M | 112.81M | 112.14M | 139.40M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 0.96 | 0.68 | 1.11 | 1.32 | 1.33 | 1.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 98.88M | 137.84M | 117.01M | 180.49M | 131.09M | 216.90M | 236.03M | 360.90M |
| Cash & ST investments | 52.09M | 37.89M | 22.74M | 69.53M | 38.17M | 123.55M | 126.73M | 163.69M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 801.51M | 1.75B | 1.73B | 2.58B | 2.54B | 2.54B | 2.55B | 4.25B |
| Total current liabilities | 26.19M | 207.90M | 134.64M | 371.48M | 281.26M | 273.68M | 197.85M | 159.95M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 268.86M | 924.54M | 769.01M | 1.13B | 985.51M | 989.27M | 963.86M | 970.01M |
| Total liabilities | 345,963,000.00 | 1,215,438,000.00 | 1,023,188,000.00 | 1,649,819,000.00 | 1,475,489,000.00 | 1,489,615,000.00 | 1,425,954,000.00 | 1,823,121,000.00 |
| Total equity | 455.55M | 537.87M | 707.54M | 929.93M | 1.07B | 1.05B | 1.12B | 2.42B |
| Retained earnings | -119.71M | -34.71M | 161.58M | 402.81M | 609.12M | 736.85M | 924.60M | 1.10B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 280.30M | 325.35M | 305.48M | 360.90M | 293.58M | 336.88M |
| Cash & ST investments | 175.61M | 107.87M | 115.74M | 163.69M | 75.85M | 70.13M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.58B | 4.25B | 4.21B | 4.25B | 4.14B | 4.18B |
| Total current liabilities | 214.36M | 164.57M | 163.97M | 159.95M | 154.86M | 130.72M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 964.76M | 965.67M | 971.99M | 970.01M | 968.02M | 967.97M |
| Total liabilities | 1,438,920,000.00 | 1,784,322,000.00 | 1,813,371,000.00 | 1,823,121,000.00 | 1,781,728,000.00 | 1,800,159,000.00 |
| Total equity | 1.14B | 2.47B | 2.40B | 2.42B | 2.36B | 2.38B |
| Retained earnings | 955.65M | 971.68M | 1.03B | 1.10B | 1.17B | 1.27B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 134.35M | 227.38M | 250.62M | 376.20M | 335.21M | 330.29M | 339.98M | 385.49M |
| Depreciation & amortization | 23.28M | 23.87M | 16.38M | 18.84M | 43.20M | 41.65M | 30.18M | 72.85M |
| Free cash flow | 131.80M | 222.15M | 242.56M | 363.52M | 329.97M | 325.12M | 338.70M | 381.33M |
| Dividends paid | -831.00K | -7.44M | -16.24M | -37.16M | -69.20M | -85.43M | -101.12M | -156.96M |
| Stock buybacks / issuance | 148.37M | -11.46M | -25.11M | -23.16M | -87.07M | -133.01M | -94.70M | -193.78M |
| Ending cash balance | 51.49M | 37.12M | 22.74M | 69.53M | 38.17M | 123.55M | 126.73M | 163.69M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 81.09M | -6.59M | 165.91M | 145.08M | 120.95M | 135.43M |
| Depreciation & amortization | 7.43M | 21.79M | 22.03M | 21.59M | 20.58M | 20.59M |
| Free cash flow | 79.51M | -7.48M | 164.83M | 144.48M | 120.11M | 134.19M |
| Dividends paid | -29.93M | -43.70M | -42.07M | -41.26M | -41.57M | -41.09M |
| Stock buybacks / issuance | 98.00K | -25.13M | -118.17M | -50.57M | -125.38M | -91.01M |
| Ending cash balance | 175.61M | 107.87M | 115.74M | 163.69M | 75.85M | 70.13M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.55 | 18.62 | 34.13 | 34.00 | 27.62 | 20.12 | 26.57 | 15.24 |
| ROA %i | 7.99 | 7.24 | 12.20 | 12.92 | 10.76 | 8.39 | 11.35 | 7.95 |
| ROIC %i | 11.08 | 10.66 | 16.04 | 16.48 | 15.07 | 12.29 | 15.88 | 10.88 |
| 5-year avg ROE %i | -- | 9.16 | 15.68 | 22.90 | 26.58 | 26.90 | 28.49 | 24.71 |
| EBIT margin %i | 25.71 | 25.95 | 40.31 | 41.89 | 46.44 | 42.95 | 50.50 | 38.58 |
| FCF / sales %i | 31.88 | 36.28 | 31.28 | 40.83 | 38.60 | 39.60 | 37.91 | 29.20 |
| Current ratioi | 3.78 | 0.66 | 0.87 | 0.49 | 0.47 | 0.79 | 1.19 | 2.26 |
| Quick ratioi | 3.67 | 0.64 | 0.82 | 0.47 | 0.44 | 0.77 | 1.15 | 2.16 |
| Debt / assetsi | 33.54 | 52.73 | 44.43 | 43.72 | 38.79 | 38.91 | 37.83 | 22.84 |
| LT debt / equityi | 59.02 | 171.89 | 108.69 | 121.29 | 92.50 | 93.95 | 85.93 | 40.01 |
| Interest coveragei | 4.97 | 4.16 | 9.19 | 16.71 | 8.46 | 4.59 | 5.83 | 7.69 |
| Revenue CAGR (3Y) %i | 19.75 | 27.15 | 23.70 | 29.14 | 11.76 | 1.93 | 0.12 | 15.18 |
| Net income CAGR (3Y) %i | 155.93 | -- | 101.89 | 63.49 | 43.88 | 0.10 | 1.24 | 6.21 |
| FCF CAGR (3Y) %i | 50.42 | 79.55 | 38.62 | 40.24 | 14.10 | 10.26 | -2.33 | 4.94 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 26.57 | 14.75 | 14.49 | 15.24 | 16.76 | 14.69 |
| ROA %i | 11.60 | 7.79 | 7.59 | 7.95 | 8.73 | 8.44 |
| ROIC %i | 15.98 | 10.71 | 10.39 | 10.88 | 11.72 | 11.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 50.87 | 43.22 | 39.80 | 38.58 | 38.59 | 42.78 |
| FCF / sales %i | 39.01 | 25.57 | 28.21 | 29.20 | 28.61 | 36.16 |
| Current ratioi | 1.31 | 1.98 | 1.86 | 2.26 | 1.90 | 2.58 |
| Quick ratioi | 1.27 | 1.90 | 1.79 | 2.16 | 1.77 | 2.41 |
| Debt / assetsi | 37.34 | 22.72 | 23.07 | 22.84 | 24.43 | 24.24 |
| LT debt / equityi | 84.29 | 39.18 | 40.52 | 40.01 | 42.88 | 42.62 |
| Interest coveragei | 6.16 | 6.25 | 6.80 | 7.69 | 8.99 | 10.97 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Investment management fees is the largest reported line at 83.21% of revenue, across 2 reported segments.
- The next-largest line, Fund administration and distribution fees, is a distant second at 16.79% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Investment management fees83.21%
Fund administration and distribution fees16.79%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.